Abstract 1846P
Background
Confronting breast cancer diagnosis, alongside with complex and challenging treatment procedures comprise an extremely stressful experience. Psychological resilience (PR) is the ability to maintain or restore normal functioning while facing the adversity, leading to better quality of life and preventing stress-related health conditions in cancer patients. We aimed to investigate the impact of early breast cancer (EBC) diagnosis on PR, distress and perception of health.
Methods
Case-controlled study included 50 newly diagnosed EBC patients and 67 women without breast cancer whose screening mammography was graded by Breast imaging-reporting and data system 1 and 2. The level of distress, perception of health and PR were assessed using the Depression Anxiety and Stress Scale 21, SF 36-Item Health Survey 1.0 and Connor-Davidson RISC-25 scale. EBC patients were questioned after confronting EBC diagnosis and before starting the treatment.
Results
The EBC patients reported deterioration of health, compared to previous year (t (df) 3,835, p<0.01), while there were no differences between groups related to general and emotional health. There was no significant statistical difference between groups regarding the levels of depression, anxiety and stress. Majority of the EBC patients and controls, 66% and 82%, had no symptoms of depression, while severe depression was noted in 10% and 3%, respectively. Around 78% EBC patients and 89% controls didn't show any anxiety. Still, 8% EBC patients and 4.5% controls were severely anxious, and 10% EBC and 4% controls were severely stressed. And finally, regarding resilience, EBC patients showed significantly higher levels of PR than healthy control (t(df) 2,530, p<0.05).
Conclusions
Confronting EBC diagnosis, possibly leads to activation of intra-individual coping mechanisms and dynamic processes of effective adaptation leading to higher PR levels of EBC patients compared with healthy controls. Further research of PR should be encouraged, by investigating the mechanisms that protect individuals and prevent stress-related health conditions, resilience research shifts a paradigm from a disease-oriented to health-oriented and focuses on mechanisms that prevent stress-related disorders.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2008P - Brazilian real-world data of immunotherapy (IO) in extensive disease small cell lung cancer (ES-SCLC)
Presenter: Flávia Duarte
Session: Poster session 05
2009P - CNS efficacy of immune checkpoint inhibitors when combined to stereotactic radiosurgery in extensive stage small cell lung cancer
Presenter: Muhammad Awidi
Session: Poster session 05
2010P - Non-invasive radiomics signature predicts response to combination chemoimmunotherapy in extensive-stage small cell lung cancer (ES SCLC)
Presenter: Stuthi Perimbeti
Session: Poster session 05
2011P - Machine-derived features of tumor infiltrating lymphocytes (TILs) as biomarkers of clinical outcomes to platinum chemotherapy in small cell lung cancer (SCLC)
Presenter: Prantesh Jain
Session: Poster session 05
2012P - Spatially resolved transcriptomics deciphers inter- and intra-tumor heterogeneity of small cell lung cancer
Presenter: xujie Sun
Session: Poster session 05
2013P - Investigating the clinical relevance of immune checkpoint expression in the peripheral blood of patients with small cell lung cancer (SCLC)
Presenter: Dimitrios Mavroudis
Session: Poster session 05
2014P - ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small cell lung cancer
Presenter: Triparna Sen
Session: Poster session 05
2015P - Association between gene characteristics and mutation abundance with the prognosis of small cell lung cancer
Presenter: Lian Yu
Session: Poster session 05
2016P - The role of galectin-1 in SCLC: Prognostic significance and therapeutic implications
Presenter: Arancha Cebrian
Session: Poster session 05
2017P - Comprehensive molecular profiling of small cell lung cancer patients treated with chemo-immunotherapy or chemotherapy alone
Presenter: Milena Urbini
Session: Poster session 05